161 related articles for article (PubMed ID: 24931722)
21. Altered expression of miRNAs and methylation of their promoters are correlated in neuroblastoma.
Maugeri M; Barbagallo D; Barbagallo C; Banelli B; Di Mauro S; Purrello F; Magro G; Ragusa M; Di Pietro C; Romani M; Purrello M
Oncotarget; 2016 Dec; 7(50):83330-83341. PubMed ID: 27829219
[TBL] [Abstract][Full Text] [Related]
22. Downregulation of miR-193a-5p correlates with lymph node metastasis and poor prognosis in colorectal cancer.
Zhang P; Ji DB; Han HB; Shi YF; Du CZ; Gu J
World J Gastroenterol; 2014 Sep; 20(34):12241-8. PubMed ID: 25232258
[TBL] [Abstract][Full Text] [Related]
23. Prognostic value of candidate microRNAs in gastric cancer: A validation study.
Zhang L; Huang Z; Zhang H; Zhu M; Zhu W; Zhou X; Liu P
Cancer Biomark; 2017; 18(3):221-230. PubMed ID: 27983528
[TBL] [Abstract][Full Text] [Related]
24. Event-free survival of infants and toddlers enrolled in the HR-NBL-1/SIOPEN trial is associated with the level of neuroblastoma mRNAs at diagnosis.
Corrias MV; Parodi S; Tchirkov A; Lammens T; Vicha A; Pasqualini C; Träger C; Yáñez Y; Dallorso S; Varesio L; Luksch R; Laureys G; Valteau-Couanet D; Canete A; Pöetschger U; Ladenstein R; Burchill SA
Pediatr Blood Cancer; 2018 Jul; 65(7):e27052. PubMed ID: 29603574
[TBL] [Abstract][Full Text] [Related]
25. IGF2BP1 harbors prognostic significance by gene gain and diverse expression in neuroblastoma.
Bell JL; Turlapati R; Liu T; Schulte JH; Hüttelmaier S
J Clin Oncol; 2015 Apr; 33(11):1285-93. PubMed ID: 25753434
[TBL] [Abstract][Full Text] [Related]
26. miRNA expression profiling enables risk stratification in archived and fresh neuroblastoma tumor samples.
De Preter K; Mestdagh P; Vermeulen J; Zeka F; Naranjo A; Bray I; Castel V; Chen C; Drozynska E; Eggert A; Hogarty MD; Izycka-Swieszewska E; London WB; Noguera R; Piqueras M; Bryan K; Schowe B; van Sluis P; Molenaar JJ; Schramm A; Schulte JH; Stallings RL; Versteeg R; Laureys G; Van Roy N; Speleman F; Vandesompele J
Clin Cancer Res; 2011 Dec; 17(24):7684-92. PubMed ID: 22031095
[TBL] [Abstract][Full Text] [Related]
27. Novel Multiple miRNA-Based Signatures for Predicting Overall Survival and Recurrence-Free Survival of Colorectal Cancer Patients.
Qian J; Zeng L; Jiang X; Zhang Z; Luo X
Med Sci Monit; 2019 Sep; 25():7258-7271. PubMed ID: 31560680
[TBL] [Abstract][Full Text] [Related]
28. Subclassification and individual survival time prediction from gene expression data of neuroblastoma patients by using CASPAR.
Oberthuer A; Kaderali L; Kahlert Y; Hero B; Westermann F; Berthold F; Brors B; Eils R; Fischer M
Clin Cancer Res; 2008 Oct; 14(20):6590-601. PubMed ID: 18927300
[TBL] [Abstract][Full Text] [Related]
29. miR-15a-5p, A Novel Prognostic Biomarker, Predicting Recurrent Colorectal Adenocarcinoma.
Kontos CK; Tsiakanikas P; Avgeris M; Papadopoulos IN; Scorilas A
Mol Diagn Ther; 2017 Aug; 21(4):453-464. PubMed ID: 28405803
[TBL] [Abstract][Full Text] [Related]
30. A new risk score for patients after first recurrence of stage 4 neuroblastoma aged ≥18 months at first diagnosis.
Kreitz K; Ernst A; Schmidt R; Simon T; Fischer M; Volland R; Hero B; Berthold F
Cancer Med; 2019 Dec; 8(17):7236-7243. PubMed ID: 31631570
[TBL] [Abstract][Full Text] [Related]
31. Tumor expression of miR-34a-3p is an independent predictor of recurrence in non-muscle-invasive bladder cancer and promising additional factor to improve predictive value of EORTC nomogram.
Juracek J; Stanik M; Vesela P; Radova L; Dolezel J; Svoboda M; Slaby O
Urol Oncol; 2019 Mar; 37(3):184.e1-184.e7. PubMed ID: 30446443
[TBL] [Abstract][Full Text] [Related]
32. Identification of microRNAs as novel biomarkers for esophageal squamous cell carcinoma: a study based on The Cancer Genome Atlas (TCGA) and bioinformatics.
Li CY; Zhang WW; Xiang JL; Wang XH; Li J; Wang JL
Chin Med J (Engl); 2019 Sep; 132(18):2213-2222. PubMed ID: 31490264
[TBL] [Abstract][Full Text] [Related]
33. Molecular subtypes of pancreatic cancer based on miRNA expression profiles have independent prognostic value.
Namkung J; Kwon W; Choi Y; Yi SG; Han S; Kang MJ; Kim SW; Park T; Jang JY
J Gastroenterol Hepatol; 2016 Jun; 31(6):1160-7. PubMed ID: 26644397
[TBL] [Abstract][Full Text] [Related]
34. Accurate prediction of neuroblastoma outcome based on miRNA expression profiles.
Schulte JH; Schowe B; Mestdagh P; Kaderali L; Kalaghatgi P; Schlierf S; Vermeulen J; Brockmeyer B; Pajtler K; Thor T; de Preter K; Speleman F; Morik K; Eggert A; Vandesompele J; Schramm A
Int J Cancer; 2010 Nov; 127(10):2374-85. PubMed ID: 20473924
[TBL] [Abstract][Full Text] [Related]
35. Identification of recurrence-related microRNAs in hepatocellular carcinoma following liver transplantation.
Han ZB; Zhong L; Teng MJ; Fan JW; Tang HM; Wu JY; Chen HY; Wang ZW; Qiu GQ; Peng ZH
Mol Oncol; 2012 Aug; 6(4):445-57. PubMed ID: 22552153
[TBL] [Abstract][Full Text] [Related]
36. Age-dependent prognostic effect by Mitosis-Karyorrhexis Index in neuroblastoma: a report from the Children's Oncology Group.
Teshiba R; Kawano S; Wang LL; He L; Naranjo A; London WB; Seeger RC; Gastier-Foster JM; Look AT; Hogarty MD; Cohn SL; Maris JM; Park JR; Shimada H
Pediatr Dev Pathol; 2014; 17(6):441-9. PubMed ID: 25207821
[TBL] [Abstract][Full Text] [Related]
37. Evaluation of miR-21 and miR-375 as prognostic biomarkers in oesophageal cancer in high-risk areas in China.
He Y; Jin J; Wang L; Hu Y; Liang D; Yang H; Liu Y; Shan B
Clin Exp Metastasis; 2017 Jan; 34(1):73-84. PubMed ID: 27885434
[TBL] [Abstract][Full Text] [Related]
38. High expression of microRNA-199a-5p is associated with superior clinical outcomes in patients with locally advanced rectal cancer.
Baek DW; Kim G; Kang BW; Kim HJ; Park SY; Park JS; Choi GS; Kang MK; Hur K; Kim JG
J Cancer Res Clin Oncol; 2020 Jan; 146(1):105-115. PubMed ID: 31781865
[TBL] [Abstract][Full Text] [Related]
39. miR-17-5p as a novel prognostic marker for hepatocellular carcinoma.
Chen L; Jiang M; Yuan W; Tang H
J Invest Surg; 2012 Jun; 25(3):156-61. PubMed ID: 22583011
[TBL] [Abstract][Full Text] [Related]
40. A 4-microRNA signature predicts lymph node metastasis and prognosis in breast cancer.
Chen X; Wang YW; Zhu WJ; Li Y; Liu L; Yin G; Gao P
Hum Pathol; 2018 Jun; 76():122-132. PubMed ID: 29555574
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
